Aclaris Therapeutics, Inc.
ACRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557746
No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Aclaris Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 133
- +9 vs. Q3 2021
- Shares held
- 56.0M
- −736.0K (−1.3%) vs. Q3 2021
- Total value
- $814.9M
- −$207.2M (−20.3%) vs. Q3 2021
- New holders
- 28
- 49 more added
- Sold out
- 19
- 37 more reduced
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 148 | $630.0M |
| Q1 2026 | 136 | $409.4M |
| Q4 2025 | 122 | $252.1M |
| Q3 2025 | 103 | $162.8M |
| Q2 2025 | 96 | $130.4M |
| Q1 2025 | 109 | $143.8M |
| Q4 2024 | 98 | $217.0M |
| Q3 2024 | 81 | $58.5M |
| Q2 2024 | 98 | $58.1M |
| Q1 2024 | 98 | $67.5M |
| Q4 2023 | 107 | $61.4M |
| Q3 2023 | 138 | $480.0M |
| Q2 2023 | 133 | $737.2M |
| Q1 2023 | 149 | $579.3M |
| Q4 2022 | 128 | $1.04B |
| Q3 2022 | 127 | $1.00B |
| Q2 2022 | 115 | $883.3M |
| Q1 2022 | 110 | $1.02B |
| Q4 2021 | 133 | $814.9M |
| Q3 2021 | 126 | $1.02B |
| Q2 2021 | 128 | $983.4M |
| Q1 2021 | 97 | $1.14B |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Aclaris Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Affinity Asset Advisors, LLC | 400,000 | $5.82M | 2.48% | +50,000+14.3% | Added |
| Frazier Management LLC | 408,329 | $5.94M | 0.46% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 466,400 | $6.78M | 0.03% | +304,557+188.2% | Added |
| Northern Trust Corp | 489,796 | $7.12M | 0.00% | −11,837−2.4% | Reduced |
| Schonfeld Strategic Advisors LLC | 490,460 | $7.13M | 0.07% | −22,415−4.4% | Reduced |
| Aisling Capital Management LP | 634,455 | $9.22M | 3.25% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 642,900 | $9.35M | 0.04% | +251,600+64.3% | Added |
| Perceptive Advisors LLC | 781,236 | $11.4M | 0.18% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 794,171 | $11.5M | 2.30% | 00.0% | Unchanged |
| Great Point Partners LLC | 800,000 | $11.6M | 2.60% | +300,000+60.0% | Added |
| Geode Capital Management, LLC | 808,462 | $11.8M | 0.00% | +12,636+1.6% | Added |
| Cormorant Asset Management, LP | 900,000 | $13.1M | 0.78% | −600,000−40.0% | Reduced |
| Adage Capital Partners GP, L.L.C. | 899,997 | $13.1M | 0.02% | −175,369−16.3% | Reduced |
| Vivo Capital, LLC | 920,982 | $13.4M | 0.81% | −19,772−2.1% | Reduced |
| OrbiMed Advisors LLC | 985,900 | $14.3M | 0.19% | +334,117+51.3% | Added |
| Citadel Advisors LLC | 1,011,772 | $14.7M | 0.02% | −51,845−4.9% | Reduced |
| Parkman Healthcare Partners LLC | 1,025,522 | $14.9M | 3.37% | −280,938−21.5% | Reduced |
| State Street Corp | 1,047,390 | $15.2M | 0.00% | −10,774−1.0% | Reduced |
| TCG Crossover Management, LLC | 1,082,213 | $15.7M | 7.37% | +1,082,213 | New |
| Laurion Capital Management LP | 1,115,075 | $16.2M | 0.28% | +622,575+126.4% | Added |
| Foresite Capital Management V, LLC | 1,258,243 | $18.3M | 4.49% | 00.0% | Unchanged |
| FMR LLC | 1,479,989 | $21.5M | 0.00% | −103,100−6.5% | Reduced |
| Renaissance Technologies LLC | 1,676,878 | $24.4M | 0.03% | −344,000−17.0% | Reduced |
| BVF Inc | 1,695,904 | $24.7M | 0.90% | +322,860+23.5% | Added |
| Holocene Advisors, LP | 2,058,618 | $29.9M | 0.16% | +103,013+5.3% | Added |
| Commodore Capital LP | 2,672,346 | $38.9M | 9.00% | +482,055+22.0% | Added |
| Vanguard Group Inc | 2,718,107 | $39.5M | 0.00% | +39,167+1.5% | Added |
| Foresite Capital Management IV, LLC | 3,399,034 | $49.4M | 10.17% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 3,861,347 | $56.1M | 1.30% | +58,115+1.5% | Added |
| BlackRock Inc. | 4,078,875 | $59.3M | 0.00% | +290,458+7.7% | Added |
| VR Adviser, LLC | 4,563,962 | $66.4M | 9.07% | 00.0% | Unchanged |
| Wellington Management Group LLP | 5,539,268 | $80.5M | 0.01% | +118,815+2.2% | Added |
| IFP Advisors, Inc | 5 | – | – | +5 | New |
| Foresite Capital Management III, LLC | 0 | $0 | 0.00% | −1,954,904−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −594,768−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −473,365−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −177,740−100.0% | Sold out |
| Jetstream Capital LLC | 0 | $0 | 0.00% | −140,000−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −87,005−100.0% | Sold out |
| Endurant Capital Management LP | 0 | $0 | 0.00% | −67,300−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −25,197−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −18,640−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −15,834−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −13,619−100.0% | Sold out |
| Baker Tilly Wealth Management, LLC | 0 | $0 | 0.00% | −11,773−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −10,539−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −6,700−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −2,383−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −765−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −288−100.0% | Sold out |
| Brewin Dolphin Ltd | 0 | $0 | 0.00% | −195−100.0% | Sold out |
| First Mercantile Trust Co | – | – | – | – | Not filed |
| Berman Capital Advisors, LLC | – | – | – | – | Not filed |